The Access to Birth Control Act adds a new duty to pharmacies under the Public Health Service Act. It requires pharmacies that receive FDA-approved contraception or related medications to ensure they can provide those products to customers without delay if in stock, and to act quickly if not in stock by offering a referral or expediting an order.
The bill also imposes guardrails against intimidation, misrepresentation, and breaches of confidentiality, and it preserves standard pharmacy decisions made under existing law.
Beyond access, the measure sets up enforcement mechanisms: civil penalties for noncompliance and a private right of action for individuals harmed by violations. It also clarifies that state laws and licensing requirements may still apply, and it establishes an effective date roughly one month after enactment.
The findings section underscores contraception as basic health care, and highlights ongoing barriers such as cost, geography, and stigma that the bill aims to address.
At a Glance
What It Does
The bill adds a new Section 249 to the Public Health Service Act. It requires pharmacies to provide FDA-approved contraception or related medications on request, either by immediate dispensing if in stock or by offering a rapid alternative (referral to a pharmacy with stock or expedited ordering). It also imposes protections for patients and staff, and sets conditions under which a pharmacy may deny service.
Who It Affects
Directly affects pharmacies and their employees, patients seeking contraception, and any suppliers involved in dispensing FDA-approved contraception or related medications.
Why It Matters
It creates a uniform federal floor for access to contraception at point of service, reduces delays and refusals, and establishes enforceable standards to curb discrimination and misrepresentation in dispensing practices.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
This bill creates a federal obligation for pharmacies to ensure access to FDA-approved contraception and related medications. When a customer asks for contraception, the pharmacy must provide it if it is in stock and do so without delay.
If the product isn’t in stock, the pharmacy must inform the customer promptly and offer either to refer the customer to another pharmacy that has it in stock or to order the product through expedited means and notify the customer when it arrives.
The bill also requires pharmacies to avoid pressuring or intimidating customers, to refrain from misrepresenting product availability or mechanism of action, and to protect medical confidentiality. It allows a pharmacy to refuse service only under standard legal/government-licensed grounds, such as lack of a valid prescription when one is required, inability to pay, or when professional clinical judgment would advise against dispensing.
Enforcement includes civil penalties up to $1,000 per day per violation (with a total cap per proceeding) and a private right of action for those harmed by violations. The act does not preempt more protective state laws and includes a date certain for when it takes effect (31 days after enactment).
The findings emphasize contraception as essential health care and note historical barriers that the bill seeks to reduce.
The Five Things You Need to Know
Pharmacies must provide FDA-approved contraception on request if in stock; otherwise they must offer a referral or expedited ordering.
Pharmacies must avoid intimidation, misrepresentation, and breaches of confidentiality in contraception-related services.
Refusals are allowed only under standard pharmacy practice conditions (no valid prescription, inability to pay, or professional judgment).
Enforcement includes civil penalties and a private right of action, with a 5-year limitations period.
The act takes effect 31 days after enactment and does not override stricter state protections.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
This section designates the act as the Access to Birth Control Act. It is a conventional opening clause that names the bill for citation and reference.
Findings
This section sets out the policy justifications for the bill. It frames contraception as basic health care, highlights historical barriers to access (cost, geography, language, discrimination), and notes that some populations experience higher rates of unintended pregnancy. The findings establish the social and public health rationale behind the duties imposed on pharmacies.
Duties of Pharmacies to Ensure Provision of Contraception and Medication Related to Contraception
The core provision creates a new obligation under the Public Health Service Act. A pharmacy that handles FDA-approved contraception or related medication must provide it without delay if in stock. If not in stock, the pharmacy must inform the customer promptly and offer to (1) refer/transfer to a nearby stockholding pharmacy or (2) order the product under standard procedures and notify the customer when it arrives. The section also prohibits intimidation, misrepresentation, or breaches of confidentiality by employees and sets permissible grounds for refusals under existing law (e.g., lack of valid prescription, inability to pay, or professional clinical judgment). It clarifies the relationship to state law, preemption limits, and enforcement mechanisms, including civil penalties and private suits, with a defined statute of limitations.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients seeking contraception who otherwise face delays or barriers, including low-income individuals and those without easy access to healthcare facilities.
- People in rural or medically underserved areas who rely on local pharmacies for contraceptive access.
- Pharmacists and pharmacy staff who operate under clearer, enforceable duties, reducing ambiguity in dispensing practices.
- Healthcare providers who can refer patients to reliable, prompt dispensing channels.
- Community clinics and public health programs that coordinate with local pharmacies to ensure uninterrupted access.
Who Bears the Cost
- Pharmacies must modify workflows and may incur staff training and system changes to meet expedited-dispensing and referral requirements.
- Pharmacies with limited resources may face higher compliance costs, particularly independent, small or rural pharmacies.
- Enforcement bodies (federal inspectors, civil action courts) may incur administrative costs to monitor and adjudicate violations.
- Insurance networks and PBMs may experience changes in dispensing patterns or administrative overhead associated with streamlined access.
- Some pharmacies may bear reputational risk or operational costs if complaints rise due to increased scrutiny.
Key Issues
The Core Tension
The central dilemma is ensuring rapid, non-discriminatory access to contraception through pharmacies while preserving professional judgment, cost control, and state-level regulatory authority.
The bill creates a robust access regime that, in practice, increases obligations on pharmacies. A central tension is balancing prompt access to contraception with respect for professional discretion and the reality of cost and operational constraints in pharmacy practice.
The enforcement framework—civil penalties and private rights of action—likely improves compliance but also raises questions about the scope of penalties, the potential for frivolous claims, and the need for clear guidance on what constitutes “without delay” or “standard procedure for expedited ordering.” The interplay with state laws and licensing regimes could produce a patchwork of compliance expectations, even as the federal standard aims for nationwide consistency.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.